Early readmission is a predictor of overall survival following isolated lung transplantation

International Surgery

Volumn 95, Issue 4, 2010, Pages 299-304

  Vigneswaran, Wickii T ^a   Helenowski, Marta ^b   Bhorade, Sangeeta M ^a   Lamounier, Fernando ^c   Alex, Charles ^c   Garrity Jr , Edward R ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Lung transplant; Morbidity; Transplant outcome

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; FEMALE; HOSPITAL READMISSION; HUMAN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; STATISTICAL MODEL; STATISTICS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE;

EID: 79955035371     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Vigneswaran WT, Bhorade S, Wolfe M, Pelletiere K, Garrity ER. Clinical pathway following lung transplantation shortens hospital length of stay without affecting outcome. Int Surg 2007;92(2):93-98
2. Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, et al. The registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2007;26(6):782-795
3. Van Enckevort PJ, KoopmanschapMA, Tenvergert E, Geertsma A, van der Bij W. Lifetime costs of lung transplantation: estimation of incremental costs. Health Econ 1997;6(5):479-489 (Pubitemid 27474916)
4. Estenne M, Maurer JR, Boehler A, Ergan JJ, Frost A. Bronchiolitis obliterance syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21(3):297-310 (Pubitemid 34224094)
5. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterance: a systematic review of recent publications. J Heart Lung Transplant 2002;21(2):271-281 (Pubitemid 34130545)
6. Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplant. Chest 2000;118(4): 1214-1217
7. Davis RD, Lau CL, Eubanks S, Messier RH, Hadsiliadis D. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003;125(3):533-542 (Pubitemid 36373899)
8. Bhorade SM, Vigneswaran WT, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000;19(12):1200-1204
9. Kelly RF, Murar J, Hong Z, et al. Low potassium dextran lung preservation solution reduces oxygen reactive species production. Ann Thorac Surg 2003;75(6):1705-1710 (Pubitemid 36677198)
10. Esmore DS, Brown R, Buckland M, et al. Techniques and results in bilateral sequential single-lung transplantation. J Card Surg 1994;9(1):1-14 (Pubitemid 24056540)
11. Strueber M, Wilhelmi M, Harringer W, Niedermeyer J, Annsar M. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 2001;19(2):190-194 (Pubitemid 32141037)
12. Garrity ER Jr, Villanueva J, Bhorade SM, Husain AN, Vigneswaran WT. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation 2001;71(6):773-777 (Pubitemid 32373693)
13. Bhorade SM, Vigneswaran WT, Lanuza D, Garrity ER. Lung transplantation at Loyola University Medical Center. In: Cecka JM, Terasaki PI, eds. Clinical Transplants. Los Angeles, CA: UCLA Immunogenetics Center, 1999:281-288
14. Hadjiliadis D, Steele M, Govert J, Davis DR, Palmer SM. Outcome of lung transplant patients admitted to the medical ICU. Chest 2004;125(3):1040-1045 (Pubitemid 38367298)
15. Zander DS, Baz MA, Visner GA, Staples ED, Donnelly WH. Analysis of early deaths after isolated lung transplantation. Chest 2001;120(1):225-232 (Pubitemid 32744884)
16. Gautum A, Fischer SA, Yango AF, Gohh RY, Morrissey PE, Monaco AP. Cell mediated immunity (CMI) and post transplant viral infections-role of functional immune assay to titrate immunosuppression. Int Immunopharmacol 2006;6(13-14):2023-2026 (Pubitemid 44855707)
17. Zeevi A, Britz JA, Bentlejewski CA, Guaspare D, Teng W. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transplant Immunol 2005;15(1):17-24 (Pubitemid 41435099)
18. Janata KR, Lu B, Sinacore J, Garrity ER, Bhorade S, Vigneswaran WT. Measurement of Immunosuppression by Cylex Immunoassay in Lung Transplantation Patients: Proceedings of the American Thoracic Society, San Diego, CA, 2005